tradingkey.logo

Beyond Air Inc

XAIR
1.150USD
+0.100+9.52%
Close 02/06, 16:00ETQuotes delayed by 15 min
9.21MMarket Cap
LossP/E TTM

Beyond Air Inc

1.150
+0.100+9.52%
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison

TradingKey Stock Score of Beyond Air Inc

Currency: USD Updated: 2026-02-06

Key Insights

Beyond Air Inc's fundamentals are relatively healthy, with industry-average ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 113 out of 205 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 9.00.In the medium term, the stock price is expected to trend down.Despite strong stock market performance and technicals over the past month, the fundamentals don't support the current trend.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Beyond Air Inc's Score

Industry at a Glance

Industry Ranking
113 / 205
Overall Ranking
294 / 4521
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Neutral

Beyond Air Inc Highlights

StrengthsRisks
Beyond Air, Inc. is a commercial-stage medical device and biopharmaceutical company dedicated to harnessing the power of endogenous and exogenous nitric oxide (NO) to improve the lives of patients suffering from respiratory illnesses, neurological disorders, and solid tumors. Its segments include Beyond Air, Beyond Cancer, and NeuroNos. It has received United States Food and Drug Administration approval for its first system, LungFit PH, for the treatment of term and near-term neonates with hypoxic respiratory failure. The Company is advancing its other LungFit systems in clinical trials for the treatment of severe lung infections such as viral community-acquired pneumonia (including COVID-19) and nontuberculous mycobacteria. It has also partnered with The Hebrew University of Jerusalem to advance a pre-clinical program dedicated to the treatment of autism spectrum disorder and other neurological disorders. Its product pipeline includes LungFit PH, LungFit PRO, LungFit GO, and others.
Growing
The company is in a growing phase, with the latest annual income totaling USD 3.71M.
Undervalued
The company’s latest PE is -0.21, at a low 3-year percentile range.
Held by The Vanguard
Star Investor The Vanguard holds 60.44K shares of this stock.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of -0.87.

Analyst Rating

Based on 5 analysts
Buy
Current Rating
9.000
Target Price
+725.69%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-02-06

The current financial score of Beyond Air Inc is 5.96, ranking 179 out of 205 in the Healthcare Equipment & Supplies industry. Its financial status is stable, and its operating efficiency is low. Its latest quarterly revenue reached 1.82M, representing a year-over-year increase of 127.82%, while its net profit experienced a year-over-year increase of 40.56%.

Score

Industry at a Glance

Previous score
5.96
Change
0

Financials

6.92

Key Metrics

Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.

Quality of Earnings

6.98

Operational Efficiency

2.83

Growth Potential

6.00

Shareholder Returns

7.07

Beyond Air Inc's Company Valuation

Currency: USD Updated: 2026-02-06

The current valuation score of Beyond Air Inc is 7.66, ranking 69 out of 205 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is -0.21, which is -97.88% below the recent high of -0.00 and -90.38% above the recent low of -0.40.

Score

Industry at a Glance

Previous score
7.66
Change
0

Valuation Dimensions

P/E
P/B
P/S
P/CF
Industry Ranking 113/205
Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-02-06

The current earnings forecast score of Beyond Air Inc is 7.60, ranking 123 out of 205 in the Healthcare Equipment & Supplies industry. The average price target is 8.50, with a high of 14.00 and a low of 5.00.

Score

Industry at a Glance

Previous score
7.60
Change
0

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 5 analysts
Buy
Current Rating
9.000
Target Price
+725.69%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

114
Total
6
Median
9
Average
Company name
Ratings
Analysts
Beyond Air Inc
XAIR
5
Stryker Corp
SYK
32
Abbott Laboratories
ABT
31
Medtronic PLC
MDT
31
Dexcom Inc
DXCM
31
Zimmer Biomet Holdings Inc
ZBH
30
1
2
3
...
23

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-02-06

The current price momentum score of Beyond Air Inc is 6.75, ranking 92 out of 205 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 2.26 and the support level at 0.44, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score
6.69
Change
0.06

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators
Sell(1)
Neutral(4)
Buy(1)
Indicators
Value
Direction
MACD(12,26,9)
-0.117
Neutral
RSI(14)
45.705
Neutral
STOCH(KDJ)(9,3,3)
13.551
Neutral
ATR(14)
0.180
Low Volatility
CCI(14)
-72.234
Neutral
Williams %R
90.244
Oversold
TRIX(12,20)
0.275
Sell
StochRSI(14)
100.000
Buy
Moving Average
Sell(5)
Neutral(0)
Buy(1)
Indicators
Value
Direction
MA5
1.117
Buy
MA10
1.209
Sell
MA20
1.425
Sell
MA50
1.166
Sell
MA100
1.630
Sell
MA200
2.482
Sell

Institutional Confidence

Currency: USD Updated: 2026-02-06

The current institutional shareholding score of Beyond Air Inc is 3.00, ranking 134 out of 205 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 21.71%, representing a quarter-over-quarter increase of 20.17%. The largest institutional shareholder is The Vanguard, holding a total of 60.44K shares, representing 0.71% of shares outstanding, with 50.56% decrease in holdings.

Score

Industry at a Glance

Previous score
3.00
Change
0

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name
Shares Held
Chg %
Alyeska Investment Group, L.P.
833.78K
+9.84%
Balyasny Asset Management LP
297.44K
-35.92%
Carey (Robert F.)
277.67K
-0.00%
Lisi (Steven A)
174.44K
+1.38%
Bleichroeder LP
86.49K
+134.29%
The Vanguard Group, Inc.
Star Investors
104.41K
+43.82%
Avenue Capital Group
54.81K
-33.12%
Kingdon Capital Management, L.L.C.
46.83K
-0.00%
Geode Capital Management, L.L.C.
42.98K
+2.55%
Wealth Effects LLC
33.76K
+142.75%
1
2

Risk Assessment

Currency: USD Updated: 2026-02-06

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Beyond Air Inc is 1.74, ranking 176 out of 205 in the Healthcare Equipment & Supplies industry. The company's beta value is 0.40. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. Beyond Air Inc’s latest ESG disclosure is at an average level in the Healthcare Equipment & Supplies industry, showing no material impact on overall risk.

Score

Industry at a Glance

Previous score
1.74
Change
0
Beta vs S&P 500 index
0.38
VaR
+8.57%
240-Day Maximum Drawdown
+89.23%
240-Day Volatility
+158.05%

Return

Best Daily Return
60 days
+150.00%
120 days
+150.00%
5 years
+150.00%
Worst Daily Return
60 days
-16.09%
120 days
-23.26%
5 years
-51.54%
Sharpe Ratio
60 days
+0.38
120 days
+0.18
5 years
-0.25

Risk Assessment

Maximum Drawdown
240 days
+89.23%
3 years
+99.49%
5 years
+99.54%
Return-to-Drawdown Ratio
240 days
-0.92
3 years
-0.33
5 years
-0.16
Skewness
240 days
+7.87
3 years
+7.06
5 years
+6.43

Volatility

Realised Volatility
240 days
+158.05%
5 years
+180.51%
Standardised True Range
240 days
+27.15%
5 years
+175.02%
Downside Risk-Adjusted Return
120 days
+68.50%
240 days
+68.50%
Maximum Daily Upside Volatility
60 days
+421.80%
Maximum Daily Downside Volatility
60 days
+156.11%

Liquidity

Average Turnover Rate
60 days
+2.77%
120 days
+2.77%
5 years
--
Turnover Deviation
20 days
-86.77%
60 days
+58.89%
120 days
+58.96%

Peer Comparison

Healthcare Equipment & Supplies
Beyond Air Inc
Beyond Air Inc
XAIR
5.98 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
LivaNova PLC
LivaNova PLC
LIVN
8.61 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Cencora Inc
Cencora Inc
COR
8.47 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Becton Dickinson and Co
Becton Dickinson and Co
BDX
8.46 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
AxoGen Inc
AxoGen Inc
AXGN
8.42 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Align Technology Inc
Align Technology Inc
ALGN
8.42 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
KeyAI